Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cell Source, Inc.CLCS · Entity 9600 | Director · President, Treasurer and CFO | March 08, 2021 | June 10, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cell Source, Inc.
Report date March 08, 2021 · Filed June 10, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2026-03-07 | Direct | 750,000 |
Reported balance
After 2021-03-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-03-08 · Grant · Acquired 750,000 · Balance 750,000 |
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2026-03-07 | Direct | 600,000 |
Reported balance
After 2021-03-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-03-08 · Grant · Acquired 600,000 · Balance 600,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2021 Filed Jun 10, 2021 17:43 UTC | Cell Source, Inc. CLCS · Entity 9600 | GrantDirector Stock Option (Right to Buy) · Derivative | 600,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001493152-21-013987 · ownership.xml · derivative · entry 2 SHIMRAT ITAMAR · CIK 0001638324 · Director · President, Treasurer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2026-03-07 Read SEC document |
| March 08, 2021 Filed Jun 10, 2021 17:43 UTC | Cell Source, Inc. CLCS · Entity 9600 | GrantEmployee Stock Option (Right to Buy) · Derivative | 750,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001493152-21-013987 · ownership.xml · derivative · entry 1 SHIMRAT ITAMAR · CIK 0001638324 · Director · President, Treasurer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2026-03-07 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.